11-Plasma Corticosteroids

Overview and Clinical Significance

11-Hydroxycorticosteroids (11-OHCS) are adrenal-derived corticosteroids, including cortisol and corticosterone, that regulate stress response, metabolism, and immune function. These compounds are primarily synthesized in the adrenal cortex under the regulation of the hypothalamic-pituitary-adrenal (HPA) axis.

Clinical Significance

  • Adrenal Insufficiency: Low plasma 11-OHCS levels may indicate inadequate adrenal function, as seen in Addison’s disease or secondary adrenal insufficiency.
  • Cushing’s Syndrome: Elevated 11-OHCS levels are commonly observed in Cushing’s syndrome, where excessive cortisol production leads to symptoms like weight gain, hypertension, and glucose intolerance.
  • Acute Stress Response: During severe infections, myocardial infarction, or metabolic crises, plasma 11-OHCS levels tend to rise as part of the body's stress adaptation.
  • Diabetes and Metabolic Disorders: Cortisol influences glucose metabolism, and abnormal 11-OHCS levels have been linked to insulin resistance and metabolic syndrome.
  • Endocrine Disorders: Variations in 11-OHCS excretion patterns can provide insights into adrenal function in disorders like congenital adrenal hyperplasia (CAH) and certain forms of androgen excess.

These steroids serve as valuable biomarkers for adrenal function and stress response, aiding in diagnosing endocrine disorders and guiding treatment decisions.

Increasing +

Decreasing -

Hyperfunction of the Adrenals

Excess Production:

  • As seen in Cushing’s syndrome (whether due to an adrenal tumor, ACTH‑secreting pituitary adenoma, or exogenous steroid exposure).

Stress Response:

  • Chronic or severe stress (even during infections) may elevate production.

Autoimmune/Inflammatory Responses:

  • Although less common, some inflammatory conditions can stimulate the adrenal axis, yielding high levels.

Adrenal Insufficiency

Conditions such as Addison’s Disease:

  • Commonly stemming from autoimmune destruction of the adrenal cortex or infections (for example, tuberculosis in some regions).

Inadequate Response in Pediatric Disorders:

  • In neonates or young children, unusually low production may signal congenital adrenal insufficiency that can impact growth and immune function.

More Info

Related

Age-Specific Considerations

Neonates and Children:

  • Have different reference intervals than adults.
  • Congenital adrenal hyperplasia or insufficiency alters expected values early in life.

Older Adults:

  • Low levels can particularly jeopardize stress responsiveness and immune regulation.

Adrenal Corticosteroid Production and Regulation

All these markers are part of the adrenal corticosteroid system, which is regulated by the hypothalamic–pituitary–adrenal (HPA) axis:

  • 11‑Plasma Oxycorticosteroids: These reflect adrenal glucocorticoid production (such as cortisol and related steroids) measured in blood.
  • 17‑Plasma Oxycorticosteroids: These indicate another set of adrenal steroids (often including precursors or androgens) in the blood.
  • 17‑Urine Ketosteroids: These are urinary metabolites derived primarily from the 17‑hydroxylated adrenal steroids. They provide an integrated view of adrenal steroid production over time.
  • Corticotropin (ACTH): This pituitary hormone stimulates the adrenal cortex to produce these corticosteroids.

In essence, ACTH drives the production of various adrenal hormones, which are then measured in blood (11‑ and 17‑oxy compounds) and metabolized to form ketosteroids excreted in urine. Together, these tests offer a comprehensive picture of adrenal function and HPA axis activity.

All Markers